{
  "description": "Regions of AAV constructs where mutations should be avoided or carefully considered",
  "version": "1.0",
  "last_updated": "2025-12-19",

  "exclusion_zones": [
    {
      "name": "ITR_boundaries",
      "region": "Within 10bp of 5' or 3' ITR boundaries",
      "severity": "CRITICAL",
      "rationale": "ITR secondary structure is essential for AAV replication and packaging. Mutations near ITR boundaries can disrupt stem-loop formation.",
      "consequences": [
        "Reduced packaging efficiency",
        "Loss of ITR function",
        "Failed AAV production"
      ],
      "recommendations": [
        "Never introduce restriction sites within 10bp of ITR boundaries",
        "Avoid any mutations in this region unless absolutely necessary",
        "If mutations required, verify ITR secondary structure predictions"
      ],
      "reference": "ITR secondary structure is critical for Rep protein binding and genome replication"
    },

    {
      "name": "Rep68_splice_acceptor",
      "region": "AAV2 nucleotides 2227-2232 (CCTGCAGG / PstI site) and surrounding context",
      "severity": "HIGH",
      "rationale": "This region contains a cryptic splice acceptor for Rep68. While not always active in typical AAV expression cassettes, mutations here can activate cryptic splicing in some contexts.",
      "consequences": [
        "Aberrant splicing of transgene mRNA",
        "Reduced transgene expression",
        "Production of truncated proteins"
      ],
      "recommendations": [
        "Avoid introducing splice consensus sequences (AG dinucleotides) near position 2227-2232 equivalent in your construct",
        "If working with full AAV genome or Rep-containing plasmids, preserve wild-type sequence",
        "For standard transfer plasmids (ITR-only), less critical but still worth noting"
      ],
      "notes": "This is primarily a concern for full AAV genome constructs or those containing Rep/Cap genes. Less relevant for standard ITR-only transfer plasmids.",
      "reference": "AAV2 Rep68 alternative splicing, PMID: 8479185"
    },

    {
      "name": "Kozak_consensus",
      "region": "6bp upstream and 3bp downstream of translation start codon (ATG)",
      "severity": "MEDIUM",
      "rationale": "Kozak consensus sequence (GCCACCATGG) affects translation initiation efficiency. Mutations can reduce protein expression.",
      "optimal_sequence": "GCCACCATGG (or GCCGCCATGG)",
      "consequences": [
        "Reduced translation efficiency",
        "Lower protein expression",
        "Leaky scanning to downstream ATGs"
      ],
      "recommendations": [
        "Preserve optimal Kozak when possible: GCC(A/G)CCATGG",
        "Critical positions: -3 (purine, preferably A), +4 (G)",
        "If modifying for restriction site removal, maintain at least -3 A/G and +4 G",
        "Test expression if significantly altering Kozak sequence"
      ],
      "reference": "Kozak consensus sequence for mammalian translation initiation"
    },

    {
      "name": "polyA_signal",
      "region": "AATAAA hexamer and surrounding 30bp region",
      "severity": "HIGH",
      "rationale": "PolyA signal (AATAAA or ATTAAA) and downstream elements are required for proper mRNA 3' end processing. Mutations can cause read-through or premature termination.",
      "consequences": [
        "Failure of mRNA 3' end cleavage/polyadenylation",
        "Read-through into vector backbone",
        "Reduced mRNA stability",
        "Lower transgene expression"
      ],
      "recommendations": [
        "Never mutate the AATAAA hexamer itself",
        "Preserve sequence context ±30bp around polyA signal",
        "Avoid introducing upstream AATAAA sites (cryptic polyA)",
        "If using synthetic polyA (bGH, SV40), maintain consensus sequence",
        "Consider using well-validated polyA signals (WPRE, bGH, SV40 late)"
      ],
      "common_polyA_signals": [
        {
          "name": "SV40 late polyA",
          "sequence": "AATAAA",
          "notes": "Most commonly used, well-validated"
        },
        {
          "name": "bGH polyA",
          "sequence": "AATAAA",
          "notes": "Compact, efficient"
        },
        {
          "name": "rbGlob polyA",
          "sequence": "AATAAA",
          "notes": "Strong signal, larger"
        }
      ],
      "reference": "Canonical polyA signal recognition, PMID: 8524414"
    },

    {
      "name": "splice_sites",
      "region": "GT-AG dinucleotides in specific contexts (5'ss: GT, 3'ss: AG)",
      "severity": "MEDIUM-HIGH",
      "rationale": "Cryptic splice sites can cause aberrant splicing, especially in constructs with introns or long transgenes.",
      "consequences": [
        "Unintended splicing events",
        "Production of truncated or aberrant proteins",
        "Reduced expression of full-length transgene"
      ],
      "recommendations": [
        "Avoid creating strong splice consensus sequences: (C/A)AG|GT(A/G)AGT (5'ss) or (C/T)nNCAG|G (3'ss)",
        "If transgene naturally contains introns, use intronless cDNA for AAV",
        "For large transgenes (>2kb), scan for cryptic splice sites and remove via silent mutations",
        "Use splice site prediction tools (MaxEntScan, NNSplice) to identify strong cryptic sites"
      ],
      "tools": [
        "MaxEntScan: http://hollywood.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html",
        "Human Splicing Finder: http://www.umd.be/HSF3/"
      ],
      "reference": "Cryptic splicing in gene therapy vectors, PMID: 11157795"
    },

    {
      "name": "promoter_core",
      "region": "TATA box and surrounding 50bp (for TATA-containing promoters)",
      "severity": "HIGH",
      "rationale": "Core promoter elements (TATA box, Inr, DPE) are critical for transcription initiation. Mutations dramatically affect expression levels.",
      "consequences": [
        "Reduced or abolished transcription",
        "Altered transcription start site",
        "Loss of promoter activity"
      ],
      "recommendations": [
        "Never mutate core promoter elements (TATA box, Inr, DPE)",
        "Preserve promoter sequence exactly as published/validated",
        "For common promoters (CMV, EF1α, CAG), use exact reference sequences",
        "If removing restriction sites from promoter region, verify activity experimentally"
      ],
      "common_promoters": [
        {
          "name": "CMV immediate early",
          "notes": "Strong, ubiquitous. Prone to silencing in some contexts."
        },
        {
          "name": "EF1α",
          "notes": "Constitutive, less prone to silencing than CMV"
        },
        {
          "name": "CAG (hybrid)",
          "notes": "Very strong, combination of CMV enhancer + chicken β-actin promoter"
        },
        {
          "name": "U6 (for shRNA)",
          "notes": "RNA Pol III promoter, very sensitive to mutations"
        }
      ],
      "reference": "Promoter architecture and function"
    },

    {
      "name": "regulatory_elements",
      "region": "Enhancers, silencers, WPRE, and other regulatory sequences",
      "severity": "MEDIUM-HIGH",
      "rationale": "Regulatory elements can dramatically affect transgene expression. Mutations may reduce or eliminate their function.",
      "consequences": [
        "Reduced expression levels",
        "Altered tissue specificity",
        "Loss of post-transcriptional enhancement (WPRE)"
      ],
      "recommendations": [
        "Use exact published sequences for regulatory elements",
        "For WPRE, avoid mutations in structured regions (3' end especially)",
        "If modifying enhancers, consider testing expression empirically",
        "Maintain spacing between regulatory elements and core promoter"
      ],
      "common_elements": [
        {
          "name": "WPRE (Woodchuck Post-transcriptional Regulatory Element)",
          "notes": "Enhances transgene expression 2-10 fold. Use WPRE3 variant (X protein deleted) for safety. Avoid mutations in 3' structured region."
        },
        {
          "name": "CMV enhancer",
          "notes": "Often combined with other promoters (e.g., CAG = CMV enhancer + chicken β-actin)"
        }
      ],
      "reference": "WPRE structure and function, PMID: 11095629"
    },

    {
      "name": "start_codon_context",
      "region": "ATG start codon and 9bp upstream",
      "severity": "MEDIUM",
      "rationale": "Context around start codon affects translation initiation. Overlaps with Kozak consensus.",
      "consequences": [
        "Reduced translation",
        "Use of alternative start codons",
        "Leaky scanning"
      ],
      "recommendations": [
        "Optimize Kozak context (see Kozak_consensus zone)",
        "Avoid upstream ATGs in good Kozak context (can cause N-terminal extension or reduced translation)",
        "If upstream ATG unavoidable, ensure it's in poor Kozak context or out-of-frame"
      ],
      "reference": "Translation initiation in eukaryotes"
    },

    {
      "name": "internal_ribosome_entry_sites",
      "region": "IRES elements (if present) ~400-600bp structured sequences",
      "severity": "CRITICAL",
      "rationale": "IRES allow cap-independent translation. Highly structured, very sensitive to mutations.",
      "consequences": [
        "Loss of IRES-mediated translation",
        "Reduced or abolished downstream cistron expression",
        "Complete loss of polycistronic expression"
      ],
      "recommendations": [
        "Treat IRES sequences as completely immutable",
        "Use exact reference sequences from validated sources",
        "Do not attempt to remove restriction sites from IRES regions",
        "If restriction sites present, use alternative cloning strategy"
      ],
      "common_IRES": [
        {
          "name": "EMCV IRES",
          "notes": "Most commonly used. ~600bp. Do not modify."
        },
        {
          "name": "CITE IRES",
          "notes": "Shorter alternative. Still highly structured."
        }
      ],
      "alternative": "Consider using 2A peptide sequences instead of IRES for polycistronic expression (more compact, less sensitive to mutations)",
      "reference": "IRES-mediated translation, PMID: 15016912"
    }
  ],

  "general_principles": [
    {
      "principle": "Preserve published sequences",
      "description": "For well-validated elements (promoters, polyA, ITRs), use exact published sequences without modification"
    },
    {
      "principle": "Buffer zones",
      "description": "Maintain ≥10bp buffer between designed elements and critical regions (ITRs, splice sites, etc.)"
    },
    {
      "principle": "Functional validation",
      "description": "If mutations are made in or near exclusion zones, validate expression/function experimentally"
    },
    {
      "principle": "Silent mutations preferred",
      "description": "When removing restriction sites from coding regions, use only silent mutations and verify with Checkpoint 8"
    },
    {
      "principle": "Avoid cryptic sites",
      "description": "Scan for cryptic splice sites, polyA signals, and start codons. Remove via silent mutations if needed."
    }
  ],

  "tools_and_resources": [
    {
      "name": "MaxEntScan",
      "purpose": "Splice site prediction",
      "url": "http://hollywood.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html"
    },
    {
      "name": "Human Splicing Finder",
      "purpose": "Comprehensive splice site analysis",
      "url": "http://www.umd.be/HSF3/"
    },
    {
      "name": "Kozak Context Calculator",
      "purpose": "Evaluate Kozak sequence strength",
      "url": "https://www.thermofisher.com/us/en/home/life-science/cloning/gene-synthesis/geneart-gene-synthesis/design-my-gene.html"
    },
    {
      "name": "PolyA Site Predictor",
      "purpose": "Identify potential polyadenylation signals",
      "url": "https://www.ncbi.nlm.nih.gov/tools/polya/"
    },
    {
      "name": "mRNA structure prediction (mfold, RNAfold)",
      "purpose": "Predict secondary structures that might affect expression",
      "url": "http://www.unafold.org/ or http://rna.tbi.univie.ac.at/"
    }
  ],

  "checkpoints_integration": {
    "Checkpoint_8": {
      "name": "Silent Mutation Verification",
      "exclusion_zones_check": "Ensure silent mutations are not introduced in exclusion zones (Kozak, promoter core, polyA signal, etc.)"
    },
    "Checkpoint_9": {
      "name": "Cloning Site Uniqueness",
      "exclusion_zones_check": "Verify that restriction sites near ITRs or in exclusion zones are accounted for in uniqueness calculation"
    },
    "Phase_0": {
      "name": "Project Setup",
      "exclusion_zones_check": "Document which exclusion zones are present in chosen backbone and expression elements"
    }
  }
}
